Hallura Ltd.: Hallura Announces Successful Topline Results of European Multi-Site Clinical Trial with its New BiOLinkMatrix HA Aesthetic Dermal Fillers

The BiOLinkMatrix by HALLURA platform, a new smooth crosslinking method, is the next generation in Hyaluronic Acid (HA) Dermal Fillers offering more natural, safe and elastic-lifting solutions

Related Keywords

Germany ,Israel ,Yokneam ,Ha Afon ,Israeli ,Kostenloser Wertpapierhandel ,Stephane Meunier ,Alona Gellerman ,Gerhard Sattler ,Shimon Eckhouse ,Rosenpark Research ,Hallura Ltd ,Prnewswire Hallura Ltd ,Hyaluronic Acid ,Dermal Fillers ,Clip Volume ,Thickness Scale ,Wrinkle Severity Rating Scale ,Mid Face Volume Deficit ,Global Aesthetic Improvement Scale ,Alon Medtech Ventures ,Per Hed ,Executive Officer ,Hallura ,Nnounces ,Uccessful ,Topline ,Results ,European ,Ulti ,Bite ,Linical ,Trial ,Iolinkmatrix ,Aesthetic ,Thermal ,Killers ,